Literature DB >> 14580759

Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony.

Constantine A Stratakis1.   

Abstract

The genetic and histopathological backgrounds of adrenocortical tumorigenesis remain poorly characterized. In other tissues, there is conclusive evidence that hyperplasia and adenomas precede cancer. In the adrenal, there are few clinical cases of either hyperplasia or adenoma associated with later development of cancer, and there are few biological studies that attempt to characterize this process molecularly. Current research focuses on the early lesions of the adrenal cortex because of their possible molecular link with carcinogenesis, and evidence of their frequent association with atypical forms of Cushing's and Conn's syndromes, obesity, hypertension and/or diabetes. These studies indicate a model for oncogenesis that is the same as that in other tissues. The rarity of adrenal cancer compared to benign lesions could be a clue to unique features of adrenocortical cells. It might also highlight the function of genes that are associated with endocrine tumors in the context of which the concept of gene 'conductors' is introduced here.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580759     DOI: 10.1016/j.tem.2003.08.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  13 in total

Review 1.  Genetics of the adrenal gland.

Authors:  Constantine A Stratakis; Ioannis Bossis
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

2.  An immortalized human cell line bearing a PRKAR1A-inactivating mutation: effects of overexpression of the wild-type Allele and other protein kinase A subunits.

Authors:  Maria Nesterova; Ioannis Bossis; Feng Wen; Anelia Horvath; Ludmila Matyakhina; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2007-12-04       Impact factor: 5.958

Review 3.  The molecular genetics of adrenocortical carcinoma.

Authors:  Ferdous M Barlaskar; Gary D Hammer
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

Review 4.  How the new tools to analyze the human genome are opening new perspectives: the use of gene expression in investigations of the adrenal cortex.

Authors:  C A Stratakis; A Horvath
Journal:  Ann Endocrinol (Paris)       Date:  2008-04-18       Impact factor: 2.478

Review 5.  Adrenal cancer in 2013: Time to individualize treatment for adrenocortical cancer?

Authors:  Constantine A Stratakis
Journal:  Nat Rev Endocrinol       Date:  2014-01-07       Impact factor: 43.330

6.  Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions.

Authors:  Madson Q Almeida; Michelle Harran; Eirini I Bimpaki; Hui-Pin Hsiao; Anelia Horvath; Chris Cheadle; Tonya Watkins; Maria Nesterova; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2011-01-20       Impact factor: 5.958

Review 7.  Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome).

Authors:  Constantine A Stratakis
Journal:  Endocr Dev       Date:  2008

Review 8.  Unraveling the molecular basis of micronodular adrenal hyperplasia.

Authors:  Anelia Horvath; Constantine A Stratakis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-06       Impact factor: 3.243

Review 9.  Mouse models of adrenocortical tumors.

Authors:  Kaitlin J Basham; Holly A Hung; Antonio M Lerario; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2015-12-08       Impact factor: 4.102

Review 10.  New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2008-11-21       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.